Last synced on 18 April 2025 at 11:05 pm

Electrical Stimulation Bladder System

Page Type
Product Code
Definition
for the treatment of patients who have complete spinal cord lesions (ASIA Classification) with intact parasympathetic innervation of the bowel and are skeletally mature and neurologically stable, to provide bowel evacuation.
Physical State
Implantable Receiver-Stimulator, and Extradural Electrodes; External controller (battery powered), External Transmitter, Battery Charger, Power Cord, External Cable and Transmitter Tester; Surgical component -Surgical stimulator, Extradural Surgical Probe, Intradural Surgical Probe, Electrode test Cable and Silicone adhesive.
Technical Method
Sacral anterior root stimulator intended to provide bladder evacuation by delivering electrical stimulation to the patient's intact spinal nerve root in order to elicit functional contraction of the muscles innervated by them. It consists of implantable, external, and surgical components.
Target Area
Electrical stimulation of the lower bowel in the GI Tract to provide fecal evacuation on demand.
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PAZ to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Electrical Stimulation Bladder System

Page Type
Product Code
Definition
for the treatment of patients who have complete spinal cord lesions (ASIA Classification) with intact parasympathetic innervation of the bowel and are skeletally mature and neurologically stable, to provide bowel evacuation.
Physical State
Implantable Receiver-Stimulator, and Extradural Electrodes; External controller (battery powered), External Transmitter, Battery Charger, Power Cord, External Cable and Transmitter Tester; Surgical component -Surgical stimulator, Extradural Surgical Probe, Intradural Surgical Probe, Electrode test Cable and Silicone adhesive.
Technical Method
Sacral anterior root stimulator intended to provide bladder evacuation by delivering electrical stimulation to the patient's intact spinal nerve root in order to elicit functional contraction of the muscles innervated by them. It consists of implantable, external, and surgical components.
Target Area
Electrical stimulation of the lower bowel in the GI Tract to provide fecal evacuation on demand.
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PAZ to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.